Cardiac resynchronization therapy: A clinical perspective;Resincronización cardíaca: Punto de vista del cardiólogo clínico

Revista Espanola de Cardiologia Suplementos

Volumn 5, Issue B, 2005, Pages

  Sánchez, Violeta ^a   Cavero, Miguel A ^b   Delgado, Juan F ^a   Pulpón, Luis A ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Bundle branch block; Electrical stimulation; Heart failure

Indexed keywords

BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; DISEASE COURSE; ECHOCARDIOGRAPHY; EXERCISE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE PACING; HEMODYNAMICS; HOSPITALIZATION; HUMAN; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT SELECTION; QRS COMPLEX; QUALITY OF LIFE; REVIEW; SURGEON; SYMPTOM;

EID: 35948997364     PISSN: 11313587     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. The world health report 1995. Bringing the gaps. World Health Statistics, World Health Organization. Disponible en: http://www.who.int/whr/1995/en
2. Rodríguez-Artalejo F, Banegas J, Guallar-Castillón P. Epidemiología de la insuficiencia cardíaca. Rev Esp Cardiol. 2004;57:163-70.
3. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult. Circulation. 2001;104:2996-3007.
4. Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation. 2003;108:2596-603.
5. Baldasseroni S, Opasich C, Gorini M, Lucci D, Marchionni N, Marini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian Network on Congestive Heart Failure. Am Heart J. 2002;143:398-405.
6. Masoudi FA, Havranek EP, Smith G, Fish RH, Steiner JF, Ordin DL, et al. Gender, age and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol. 2003;41:217-23.
7. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhyhtmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to update the 1998 pacemaker guidelines). Circulation. 2002;106:2145-61.
8. Havranek EP, Masoudi FA, Wesfall KA, Wolfe P, Ordin DL, Krumholz HM, et al. Spectrum of heart failure in older patients: results from the National Heart Failure project. Am Heart J. 2002;143:412-7.
9. Yu CM, Chau E, Sanderson JE, Fan K,Tang M, Fung W, et al. Tissue Doppler echocardiographic evidence of reverse remodelling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation. 2002;105:438-45.
10. Nelson GS, Berger RD, Barry JF, Talbot M, Spinelli JC, Hare JM, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 2000;102:3053-9.
11. Bristol RM, Saxon LA, Boehmer JB, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-9.
12. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-49.
13. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al, for the MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-53.
14. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873-80.
15. Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J. 2002;23:1780-7.
16. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, et al. Long-term clinical effect of hemodynamically optimized cardiac resyncronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39:2026-33.
17. Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier AR, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol. 2003;42:2109-16.
18. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003;42:1454-9.
19. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685-94.
20. Stellbrink C, Sinha AM, Diem B, Auricchio A, Boccanelli S, Brugada J, et al. Implantable cardioverter-defibrillators with or without cardiac resynchronization therapy-multiple therapy in a single device: a review with special reference to the PACMAN study. Eur Heart J. 2000;21:1246-50.
21. Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation. 2004;110:2864-8.
22. Hauer RN, Aliot E, Block M, Capucci A, Luderitz B, Santini M, et al. Indications for ICD therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. Eur Heart J. 2001;22:1074-81.
23. Bantz K, Gras D. Cardiac resynchronization therapy: a model to assess the economical value of this new technology (abstract). Eur Heart J. 2003;24 Suppl:364.
24. Saxon LA, Stevenson WG, Middlekauff HR, Stevenson LW. Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacema-kers. Am Heart J. 1993;125:1306-10.
25. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual-chamber pacing and VVI Implantable Defibrillator (DAVID) trial. JAMA. 2002;288:3115-23.
26. Leon AR, Greenberg JM, Kanuru N, Baker CM, Mera FV, Smith AL, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation. Effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol. 2002;39:1258-63.
27. Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and «narrow» QRS. J Am Coll Cardiol. 2003;42:2117-24.